Intra-Cellular Therapies (STU:23I) Other Stockholders Equity : €0.0 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Intra-Cellular Therapies Other Stockholders Equity?

Intra-Cellular Therapies's Other Stockholders Equity for the quarter that ended in Mar. 2024 was €0.0 Mil.

Intra-Cellular Therapies's quarterly Other Stockholders Equity increased from Sep. 2023 (€0.0 Mil) to Dec. 2023 (€0.0 Mil) but then declined from Dec. 2023 (€0.0 Mil) to Mar. 2024 (€0.0 Mil).

Intra-Cellular Therapies's annual Other Stockholders Equity declined from Dec. 2021 (€0.0 Mil) to Dec. 2022 (€0.0 Mil) but then increased from Dec. 2022 (€0.0 Mil) to Dec. 2023 (€0.0 Mil).

Intra-Cellular Therapies Other Stockholders Equity Historical Data

The historical data trend for Intra-Cellular Therapies's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intra-Cellular Therapies Other Stockholders Equity Chart

Intra-Cellular Therapies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

Intra-Cellular Therapies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Stockholders Equity	Get a 7-Day Free Trial															-	-	-	-	-

Intra-Cellular Therapies Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Intra-Cellular Therapies Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Intra-Cellular Therapies's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Intra-Cellular Therapies (STU:23I) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intra-Cellular Therapies Inc (STU:23I) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

ITCI:USA ITCI:Mexico 23I:Germany

Address

430 East 29th Street, New York, NY, USA, 10016

Website

https://www.intracellulartherapies.com

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Intra-Cellular Therapies (STU:23I) Headlines

No Headlines